Literature DB >> 7875744

Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin.

H H Mu1, W A Sewell.   

Abstract

Interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) are cytokines with important functions in regulating immune responses. IFN-gamma may be produced by cells responsible for delayed-type hypersensitivity (DTH), whereas IL-4 is essential for IgE production. Pertussis toxin (PT) from Bordetella pertussis enhances both DTH and IgE responses, and causes enhancement of both IFN-gamma and IL-4 secretion in immunized mice. In the present study, the effects of neutralizing monoclonal antibodies against IFN-gamma or IL-4 on DTH, serum IgE and cytokine production were assessed. Treatment with a monoclonal anti-IL-4 antibody at the time of immunization caused a striking increase in DTH responses, and elicited enhanced IFN-gamma expression, while inhibition of the production of IL-4 and IgE was observed. By contrast, injection of a monoclonal anti-IFN-gamma antibody was followed by significant but not complete suppression of DTH reactions. IFN-gamma secretion was also inhibited, whereas IL-4 production and serum IgE were increased. Thus antibodies to IL-4 and IFN-gamma, given at the time of immunization, can profoundly influence the nature of short-term immune responses elicited by PT in immunized mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7875744      PMCID: PMC1415058     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Presence of single-stranded DNA in PCR products of slow electrophoretic mobility.

Authors:  J E Valentine; M J Boyle; W A Sewell; N M Gough
Journal:  Biotechniques       Date:  1992-08       Impact factor: 1.993

Review 2.  Diversity of cytokine synthesis and function of mouse CD4+ T cells.

Authors:  T R Mosmann; J H Schumacher; N F Street; R Budd; A O'Garra; T A Fong; M W Bond; K W Moore; A Sher; D F Fiorentino
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

3.  Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells.

Authors:  A Gross; S Z Ben-Sasson; W E Paul
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

4.  The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent.

Authors:  J H Schumacher; A O'Garra; B Shrader; A van Kimmenade; M W Bond; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

5.  The relationship between humoral and cell-mediated immunity.

Authors:  C R Parish
Journal:  Transplant Rev       Date:  1972

6.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

Review 7.  Differential regulation of murine T lymphocyte subsets.

Authors:  F W Fitch; M D McKisic; D W Lancki; T F Gajewski
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.

Authors:  R A Seder; W E Paul; M M Davis; B Fazekas de St Groth
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

9.  Generation and analysis of interleukin-4 deficient mice.

Authors:  R Kühn; K Rajewsky; W Müller
Journal:  Science       Date:  1991-11-01       Impact factor: 47.728

10.  Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.

Authors:  K Varkila; R Chatelain; L M Leal; R L Coffman
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

View more
  8 in total

1.  Impaired delayed-type hypersensitivity response in mutant mice secreting soluble CD4 without expression of membrane-bound CD4.

Authors:  C R Wang; A Hino; T Yoshimoto; H Nagase; T Kato; K Hirokawa; A Matsuzawa; H Nariuchi
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

2.  Differences in coughing and other responses to intrabronchial infection with Bordetella pertussis among strains of rats.

Authors:  E Hall; R Parton; A C Wardlaw
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  Effects of bisphenol A on antigen-specific antibody production, proliferative responses of lymphoid cells, and TH1 and TH2 immune responses in mice.

Authors:  Shin Yoshino; Kouya Yamaki; Rie Yanagisawa; Hirohisa Takano; Hideyuki Hayashi; Yoki Mori
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

4.  Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.

Authors:  Darren P Ennis; Joseph P Cassidy; Bernard P Mahon
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

5.  Prenatal exposure to bisphenol A up-regulates immune responses, including T helper 1 and T helper 2 responses, in mice.

Authors:  Shin Yoshino; Kouya Yamaki; Xiaojuan Li; Tao Sai; Rie Yanagisawa; Hirohisa Takano; Shinji Taneda; Hideyuki Hayashi; Yoki Mori
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

6.  Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses.

Authors:  Y Zhang; K H Rogers; D B Lewis
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

7.  Poplar bark lipids enhance mouse immunity by inducing T cell proliferation and differentiation.

Authors:  Jinxiu Tang; Xiuli Wei; Youzhi Li; Linlin Jiang; Tao Feng; Hongwei Zhu; Meng Li; Guozhong Chen; Xin Yu; Jianlong Zhang; Xingxiao Zhang
Journal:  J Vet Med Sci       Date:  2020-07-14       Impact factor: 1.267

8.  A cross-sectional study of the relationship between reported human papillomavirus vaccine exposure and the incidence of reported asthma in the United States.

Authors:  David A Geier; Janet K Kern; Mark R Geier
Journal:  SAGE Open Med       Date:  2019-01-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.